General
Preferred name
MYCOPHENOLIC ACID
Synonyms
Mycophenolic acid D3 ()
Mycophenolate D3 ()
RS-61443 ()
Mycophenolate ()
RS-61443 D3 ()
MYCOPHENOLATE SODIUM ()
Mycophenolate, RS-61443 ()
RS-61443 [as mofetil] ()
Myfortic ()
Mycophenolate mofetil impurity, mycophenolic acid- ()
NSC-129185 ()
68618 ()
Mycophenolic acid sodium salt ()
Mycophenolic sodium ()
Sodium mycophenalate ()
Mycophenolic sod ()
Ceptava ()
NSC-116072 ()
ERL-080 ()
ERL 080 ()
Mycophenolic Acid ()
4-Methylumbelliferyl-?-L-Iduronide 2-sulfate (sodium salt) ()
P&D ID
PD001641
CAS
24280-93-1
483-60-3
1162256-90-7
37415-62-6
Tags
natural product
drug
available
Approved by
FDA
First approval
2004
Drug Status
investigational
approved
Drug indication
Antineoplastic
Organ transplant rejection
Middle East Respiratory Syndrome (MERS)
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION An antibacterial substance derived from Penicillium stoloniferum, and related species. Inhibits inosine-5'-monophosphate dehydrogenase (IMPDH). (GtoPdb)
DESCRIPTION Cyclooxygenase (COX-1) inhibitor (Tocris Bioactive Compound Library)
DESCRIPTION Inosine monophosphatase dehydrogenase inhibitor (Tocriscreen Plus)
DESCRIPTION Inosine monophosphatase dehydrogenase inhibitor (Tocriscreen Total)
Cell lines
22
Organisms
24
Compound Sets
33
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP Approved Drugs
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Other bioactive compounds
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Plus
Tocriscreen Total
ZINC Tool Compounds
External IDs
65
Properties
(calculated by RDKit )
Molecular Weight
320.13
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
6
Ring Count
2
Aromatic Ring Count
1
cLogP
2.73
TPSA
93.06
Fraction CSP3
0.41
Chiral centers
0.0
Largest ring
6.0
QED
0.62
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Enzymes
MOA
bacterial inosine-5-monophosphate dehydrogenase inhibitor
Inhibitor
Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors
Immunosuppressant
IMPDH inhibitor
Antiviral
dehydrogenase inhibitor, inositol monophosphatase inhibitor
Target
Inosine-5'-monophosphate dehydrogenase (IMPDH)
DH
UGT
IMPDH1, IMPDH2
antibiotic
Bacterial
Dengue virus
Endogenous Metabolite
Flavivirus
Fungal
Antineoplastic and Immunosuppressive Antibiotics,Dehydrogenase,Selection Antibiotics for Transfected Cell
Pathway
Metabolism
Anti-infection
Apoptosis
Metabolic Enzyme/Protease
Primary Target
Other Dehydrogenases
Member status
virtual
Indication
organ rejection
Therapeutic Class
Antiviral Agents
Source data